Free Trial

Thrivent Financial for Lutherans Sells 662,000 Shares of Paragon 28, Inc. (NYSE:FNA)

Paragon 28 logo with Medical background

Thrivent Financial for Lutherans cut its position in shares of Paragon 28, Inc. (NYSE:FNA - Free Report) by 98.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,500 shares of the company's stock after selling 662,000 shares during the quarter. Thrivent Financial for Lutherans' holdings in Paragon 28 were worth $129,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Intech Investment Management LLC purchased a new stake in Paragon 28 in the 3rd quarter worth about $70,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Paragon 28 by 4.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 343,565 shares of the company's stock valued at $2,295,000 after buying an additional 15,064 shares in the last quarter. State Street Corp increased its holdings in shares of Paragon 28 by 2.6% in the third quarter. State Street Corp now owns 1,563,331 shares of the company's stock worth $10,443,000 after buying an additional 39,075 shares during the period. Wellington Management Group LLP grew its holdings in Paragon 28 by 7.0% in the 3rd quarter. Wellington Management Group LLP now owns 694,799 shares of the company's stock worth $4,641,000 after acquiring an additional 45,215 shares during the last quarter. Finally, Barclays PLC grew its position in shares of Paragon 28 by 180.6% in the 3rd quarter. Barclays PLC now owns 84,812 shares of the company's stock worth $567,000 after buying an additional 54,591 shares during the last quarter. 63.57% of the stock is currently owned by institutional investors.

Insider Transactions at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 27,142 shares of Paragon 28 stock in a transaction on Monday, January 27th. The shares were sold at an average price of $11.62, for a total value of $315,390.04. Following the sale, the insider now directly owns 10,313,841 shares in the company, valued at approximately $119,846,832.42. The trade was a 0.26 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold a total of 1,875,984 shares of company stock valued at $24,359,971 over the last 90 days. Company insiders own 15.32% of the company's stock.

Paragon 28 Stock Performance

Shares of NYSE:FNA traded down $0.02 during mid-day trading on Wednesday, reaching $13.00. 5,087,639 shares of the company traded hands, compared to its average volume of 934,965. The company's 50 day moving average price is $13.03 and its 200-day moving average price is $10.26. The firm has a market cap of $1.09 billion, a PE ratio of -17.57 and a beta of 1.47. Paragon 28, Inc. has a 52 week low of $4.65 and a 52 week high of $13.13. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60.

Paragon 28 (NYSE:FNA - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.01). Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The firm had revenue of $71.75 million during the quarter, compared to the consensus estimate of $70.81 million. On average, equities analysts expect that Paragon 28, Inc. will post -0.64 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Stephens reaffirmed an "equal weight" rating and set a $13.00 price objective (down from $14.00) on shares of Paragon 28 in a research report on Thursday, January 30th. William Blair cut Paragon 28 from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Needham & Company LLC reiterated a "hold" rating and set a $13.00 price objective on shares of Paragon 28 in a research report on Wednesday, January 29th. Finally, Canaccord Genuity Group set a $13.00 price target on shares of Paragon 28 in a research report on Wednesday, January 29th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $14.20.

Get Our Latest Stock Analysis on FNA

Paragon 28 Profile

(Free Report)

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

Read More

Institutional Ownership by Quarter for Paragon 28 (NYSE:FNA)

Should You Invest $1,000 in Paragon 28 Right Now?

Before you consider Paragon 28, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paragon 28 wasn't on the list.

While Paragon 28 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines